James Yu
Impact in
-
- Cancer Immunotherapy and Biomarkers
- Colorectal Cancer Treatments and Studies
-
- Hepatocellular Carcinoma Treatment and Prognosis
Papers in
- Oncology 13
- Cancer Immunotherapy and Biomarkers 6
- Colorectal Cancer Treatments and Studies 3
-
- Fibroblast Growth Factor Research 3
- Co-authors
- Richard D. Kim (11 shared papers)Amit Mahipal (3 shared papers)Anuhya Kommalapati (2 shared papers)Sri Harsha Tella (1 shared paper)Luis A. Díaz (1 shared paper)Kristen K. Ciombor (1 shared paper)İbrahim Halil Şahin (1 shared paper)Elaine Tan (2 shared papers)
- Journals
- Cancers (4 papers)Transplantation and Cellular Therapy (2 papers)Critical Reviews in Oncology/Hematology (1 paper)Biomedicines (1 paper)Blood (1 paper)
- Partner nations
- United States
In The Last Decade
James Yu
23 papers receiving 256 citations
Peers
Comparison fields: 5 of 58
- Oncology 101
- Hepatology 20
- Pathology and Forensic Medicine 39
- Cancer Research 22
- Microbiology 1
Countries citing papers authored by James Yu
This map shows the geographic impact of James Yu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James Yu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James Yu more than expected).
Fields of papers citing papers by James Yu
This network shows the impact of papers produced by James Yu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James Yu. The network helps show where James Yu may publish in the future.
Co-authors
The 25 scholars most cited alongside James Yu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 27 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 43 | |
| 2 | 2022 | 41 | |
| 3 | 2021 | 28 | |
| 4 | 2020 | 24 | |
| 5 | 2021 | 24 | |
| 6 | 2022 | 14 | |
| 7 | 2021 | 13 | |
| 8 | 2023 | 11 | |
| 9 | 2021 | 10 | |
| 10 | 2025 | 7 | |
| 11 | 2024 | 6 | |
| 12 | 2025 | 6 | |
| 13 | 2021 | 6 | |
| 14 | 2021 | 5 | |
| 15 | 2021 | 4 | |
| 16 | 2024 | 3 | |
| 17 | 2020 | 3 | |
| 18 | 2025 | 3 | |
| 19 | 2021 | 3 | |
| 20 | 2020 | 3 |
About James Yu
James Yu is a scholar working on Oncology, Molecular Biology, Pathology and Forensic Medicine, Pulmonary and Respiratory Medicine and Surgery, having authored 27 papers that have together received 261 indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (6 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (4 papers), Acute Myeloid Leukemia Research (4 papers), Fibroblast Growth Factor Research (3 papers), Colorectal Cancer Treatments and Studies (3 papers), Hepatocellular Carcinoma Treatment and Prognosis (3 papers), Gastric Cancer Management and Outcomes (3 papers) and Myeloproliferative Neoplasms: Diagnosis and Treatment (2 papers). The work is most often cited by research in Oncology (101 citations), Hepatology (20 citations), Pathology and Forensic Medicine (39 citations), Cancer Research (22 citations) and Microbiology (1 citation). James Yu has collaborated with scholars based in United States. Frequent co-authors include Richard D. Kim, Amit Mahipal, Anuhya Kommalapati, Sri Harsha Tella, Luis A. Díaz, Kristen K. Ciombor, İbrahim Halil Şahin, Elaine Tan, Dae Won Kim and Juan Carlos Varela. Their work appears in journals such as Cancers, Transplantation and Cellular Therapy, Critical Reviews in Oncology/Hematology, Biomedicines and Blood.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.